analyst
OL
NASDAQ · OLMA
Olema Pharmaceuticals, Inc.
Healthcare · Biotechnology
$8.25
Down-$0.33 (-4.00%)
Updated Oct 7, 2026, 12:13 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.17B
- P/E ratio
- -18.05
- Dividend yield
- 0.00%
- 52-week range
- $6.65 – $36.26
- Volume
- 1.01M
- Avg. volume
- 3.41M
Price performance · OLMA
OLMA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
OLMA closed at $8.25 after 20 trading sessions, down 24.90% for the selected period.
- Last close
- $8.25
- Period change
- -24.90%
- Period low
- $8.23
- Period high
- $10.99
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $8.28 | $8.30 | $7.85 | $8.25 | 1.01M |
| Oct 2, 2026 | $8.39 | $8.52 | $8.10 | $8.225 | 1.07M |
| Oct 1, 2026 | $8.58 | $8.66 | $8.19 | $8.27 | 1.01M |
| Sep 30, 2026 | $8.59 | $8.86 | $8.42 | $8.64 | 1.54M |
| Sep 29, 2026 | $8.60 | $8.73 | $8.46 | $8.54 | 1.08M |
| Sep 28, 2026 | $8.71 | $8.85 | $8.40 | $8.61 | 979.23K |
| Sep 25, 2026 | $9.04 | $9.04 | $8.57 | $8.75 | 1.38M |
| Sep 24, 2026 | $8.79 | $9.27 | $8.59 | $9.04 | 1.49M |
| Sep 23, 2026 | $9.64 | $9.64 | $8.70 | $8.83 | 1.64M |
| Sep 22, 2026 | $9.66 | $9.815 | $9.56 | $9.64 | 1.49M |
| Sep 21, 2026 | $9.95 | $10.13 | $9.61 | $9.63 | 1.07M |
| Sep 18, 2026 | $9.88 | $9.93 | $9.75 | $9.82 | 3.06M |
| Sep 17, 2026 | $9.89 | $10.35 | $9.73 | $9.90 | 1.09M |
| Sep 16, 2026 | $9.86 | $9.93 | $9.44 | $9.73 | 1.25M |
| Sep 15, 2026 | $10.29 | $10.34 | $9.65 | $9.78 | 1.73M |
| Sep 14, 2026 | $9.99 | $10.37 | $9.79 | $10.29 | 1.82M |
| Sep 11, 2026 | $10.79 | $10.86 | $10.18 | $10.22 | 1.01M |
| Sep 10, 2026 | $10.19 | $10.98 | $10.11 | $10.69 | 1.12M |
| Sep 9, 2026 | $11.13 | $11.18 | $10.35 | $10.36 | 863.84K |
| Sep 8, 2026 | $10.61 | $11.055 | $10.46 | $10.985 | 736.72K |
Latest OLMA news
The latest Smart Investors Daily articles mentioning OLMA.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

